AXL –GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases

ConclusionsAXL –GAS6 co-expression represents a potential independent prognostic biomarker for survival outcome in NSCLC BM patients.
Source: Journal of Cancer Research and Clinical Oncology - Category: Cancer & Oncology Source Type: research